Moderna Covid vaccine efficacy falls slightly to 90% in US trial

Covid-19: Moderna and Novavax vaccines to be tested in mixing vaccines trial
14 April 2021
Clot questions over AstraZeneca and J&J vaccine
14 April 2021

Moderna Covid vaccine efficacy falls slightly to 90% in US trial

US biotech company Moderna announced COVID vaccine is 90 percent effective against all forms of the disease and 95 percent effective against severe disease.

Comments are closed.